Terlivaz
Terlivaz (terlipressin) is a medication that helps to improve kidney function in people with hepatorenal syndrome (HRS). It's the first FDA-approved medication for this condition. Terlivaz (terlipressin) is only available in the hospital, and is given as an intravenous (IV, or into the veins) injection by a trained healthcare provider. Terlivaz (terlipressin) can put you at risk for serious breathing problems, so your provider will monitor your oxygen level closely while you receive treatment.
What is Terlivaz (terlipressin) ?
What is Terlivaz (terlipressin) used for?
- Improving kidney function in people with hepatorenal syndrome (HRS) with acute (sudden) kidney failure
Drug facts
| Common Brands | Terlivaz |
|---|---|
| Drug Class | Synthetic vasopressin analog |
| Controlled Substance Classification | Not a controlled medication |
| Generic Status | No lower-cost generic available |
| Availability | Prescription only |